Search research articles
Contact Us
Filters
Showing results (11-20 of 121) with videos related to
Page
of 13
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics
|
December 1, 1993
The importance of modeling interoccasion variability in population pharmacokinetic analyses
M O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics
|
June 1, 1994
Estimating bioavailability when clearance varies with time
M O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics
|
June 16, 2007
Diagnosing model diagnostics
M O Karlsson, R M Savic
Biopharmaceutics & Drug Disposition
|
January 1, 1994
Dose dependent absorption and linear disposition of cyclosporin A in rat
A Lindberg-Freijs, M O Karlsson
Computer Methods and Programs in Biomedicine
|
April 9, 1999
Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
E N Jonsson, M O Karlsson
Pharmaceutical Research
|
October 2, 1998
Automated covariate model building within NONMEM
E N Jonsson, M O Karlsson
European Journal of Pharmacology
|
January 12, 1988
Characterization of high-affinity binding sites for the antitussive [3H]noscapine in guinea pig brain tissue
M O Karlsson, B Dahlström, A Neil
Clinical Pharmacology and Therapeutics
|
September 1, 1992
A comparison between the semisimultaneous and the stable isotope techniques for bioavailability estimation of terbutaline in humans
U Bredberg, M O Karlsson, L Borgström
Pharmaceutical Research
|
September 1, 1999
Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selection
S Sadray, E N Jonsson, M O Karlsson
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1998
Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia
L Brynne, M O Karlsson, L K Paalzow
Page
of 13
Search research articles
Search
Showing results (11-20 of 121) with videos related to
Sort By:
Page
of 13
Journal of Pharmacokinetics and Biopharmaceutics
|
December 1, 1993
The importance of modeling interoccasion variability in population pharmacokinetic analyses
M O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics
|
June 1, 1994
Estimating bioavailability when clearance varies with time
M O Karlsson, L B Sheiner
Clinical Pharmacology and Therapeutics
|
June 16, 2007
Diagnosing model diagnostics
M O Karlsson, R M Savic
Biopharmaceutics & Drug Disposition
|
January 1, 1994
Dose dependent absorption and linear disposition of cyclosporin A in rat
A Lindberg-Freijs, M O Karlsson
Computer Methods and Programs in Biomedicine
|
April 9, 1999
Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
E N Jonsson, M O Karlsson
Pharmaceutical Research
|
October 2, 1998
Automated covariate model building within NONMEM
E N Jonsson, M O Karlsson
European Journal of Pharmacology
|
January 12, 1988
Characterization of high-affinity binding sites for the antitussive [3H]noscapine in guinea pig brain tissue
M O Karlsson, B Dahlström, A Neil
Clinical Pharmacology and Therapeutics
|
September 1, 1992
A comparison between the semisimultaneous and the stable isotope techniques for bioavailability estimation of terbutaline in humans
U Bredberg, M O Karlsson, L Borgström
Pharmaceutical Research
|
September 1, 1999
Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selection
S Sadray, E N Jonsson, M O Karlsson
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1998
Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia
L Brynne, M O Karlsson, L K Paalzow
Page
of 13